World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
63
Citations
23539
World Ranking
9987
National Ranking
764

Alison H. Banham publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Alison H. Banham sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 192 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Alison H. Banham D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Alison H. Banham sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 63 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Alison H. Banham is affiliated with the University of Oxford in the United Kingdom. Their research primarily focuses on biochemistry, genetics, and molecular biology, with significant work in the fields of medicine, molecular biology, oncology, immunology, and cancer research.

Their studies encompass a range of topics, including:

  • Cell Adhesion Molecules Research
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Angiogenesis and VEGF in Cancer
  • Adenosine and Purinergic Signaling
  • Enzyme function and inhibition

Alison H. Banham has contributed to several notable publications. Recent papers include:

  • "Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration," 2020, British Journal of Cancer
  • "CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model," 2020, Frontiers in Oncology
  • "Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling," 2021, Scientific Reports
  • "High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations," 2020, PLoS ONE
  • "ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype," 2021, International Journal of Molecular Sciences

The frequent co-authors who have collaborated with Banham include:

  • Adrian L. Harris
  • Helen Sheldon
  • Esther Bridges
  • Salwa Lin
  • Demin Li

The main venues where their work has been published are:

  • PLoS ONE
  • British Journal of Cancer
  • Frontiers in Oncology
  • Scientific Reports
  • International Journal of Molecular Sciences

Alison H. Banham's research spans multiple subfields including molecular biology, oncology, immunology, and cancer research, with additional focus on immunology and allergy. Their scientific output integrates studies on cellular mechanisms relevant to cancer progression, immune cell dynamics, and molecular pathways involved in tumor biology and therapy.

Best Publications

  • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

    Christine P. Hans;Dennis D. Weisenburger;Timothy C. Greiner;Randy D. Gascoyne

  • Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.

    Charles H. Lawrie;Shira Gal;Heather M. Dunlop;Beena Pushkaran

  • Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

    Gaynor J. Bates;Stephen B. Fox;Cheng Han;Russell D. Leek

  • Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.

    Giovanna Roncador;Philip J. Brown;Lorena Maestre;Sophie Hue

  • A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

    William W L Choi;Dennis D. Weisenburger;Timothy Charles Greiner;Miguel A. Piris

  • High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

    Joaquim Carreras;Armando Lopez-Guillermo;Armando Lopez-Guillermo;Bridget C. Fox;Bridget C. Fox;Lluis Colomo;Lluis Colomo

  • CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients

    Ashley M. Miller;Kajsa Lundberg;Volkan Özenci;Alison H. Banham

  • Expansion of CD4+CD25+and FOXP3+ Regulatory T Cells during the Follicular Phase of the Menstrual Cycle: Implications for Human Reproduction

    Lourdes Arruvito;Marianela Sanz;Alison H. Banham;Leonardo Fainboim

  • Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.

    Tomás Álvaro;Marylène Lejeune;Ma Teresa Salvadó;Ramón Bosch

  • Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

    Sharon L. Barrans;James A. L. Fenton;Alison Banham;Roger G. Owen

  • A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis

    Massimo Masiero;Filipa Costa Simões;Hee Dong Han;Cameron Snell

  • Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease

    Masayuki Saruta;Qi T. Yu;Phillip R. Fleshner;Pierre Yves Mantel

  • Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.

    Qi T. Yu;Masayuki Saruta;Armine Avanesyan;Phillip R. Fleshner

  • Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients.

    Khoon Lin Ling;Sarah E. Pratap;Gaynor J. Bates;Baljit Singh

  • The notch ligand JAGGED1 as a target for anti-tumor therapy.

    Demin Li;Massimo Masiero;Alison H. Banham;Adrian L. Harris

  • CD molecules 2006 — Human cell differentiation molecules

    Heddy Zola;Bernadette Swart;Alison Banham;Simon Barry

  • Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia

    Russell J. Ferland;Luis Federico Batiz;Jason Neal;Gewei Lian

  • Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection☆

    Scott M. Ward;Bridget C. Fox;Philip J. Brown;Joy Worthington

  • FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma.

    G Roncador;J F Garcia;L Maestre;E Lucas

  • FOXP3+ regulatory T cells: Current controversies and future perspectives.

    Alison H. Banham;Fiona M. Powrie;Elisabeth Suri-Payer

Frequent Co-Authors

Karen Pulford
Karen Pulford University of Oxford
adrian l harris
adrian l harris University of Oxford
Stephen B. Fox
Stephen B. Fox Peter MacCallum Cancer Centre
David Y. Mason
David Y. Mason John Radcliffe Hospital
Paola Bovolenta
Paola Bovolenta Spanish National Research Council
Bruce E. Torbett
Bruce E. Torbett Seattle Children's Hospital
Elizabeth M. Simpson
Elizabeth M. Simpson University of British Columbia
Wyeth W. Wasserman
Wyeth W. Wasserman University of British Columbia
Reiner A. Veitia
Reiner A. Veitia Université Paris Cité
Peggy J. Farnham
Peggy J. Farnham University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens the door to diverse career pathways, especially in the rapidly growing healthcare sector. One increasingly popular route is medical coding and health information management, both of which can be pursued online for maximum flexibility.

If you’re comparing ccs vs cpc salary prospects, it’s important to know that credentials like Certified Coding Specialist (CCS) and Certified Professional Coder (CPC) each offer distinct salary ranges and career benefits. Both are highly regarded and can be achieved through accredited online programs.

Wondering what is medical coding salary? Medical coders in the U.S. can expect competitive average earnings, especially with growing demand for remote and specialized roles. For many, medical coding answers the question: is medical coding a good career? The job offers stability, flexibility, and a clear career advancement pathway.

To get started, consider enrolling in one of the online health information management degree programs. These offer affordable, flexible options to build new skills and open the door to dynamic health information careers after your Biology or Biochemistry studies.

Best Scientists Citing Alison H. Banham

Trending Scientists

Recently Published Articles